Ensysce Biosciences, Inc.
ENSC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001716947
In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $444.2K in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 18
- 13F valueReported value at the end of Q2 2026
- $261.1K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ENSC, Q2 2026
No superinvestor reported holding ENSC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Ensysce Biosciences, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)6:06 AM ET | Apr 23-Aug 7 | 117 daysLate | Gower Bob GDirector | PPurchase | +908.6K | $0.4888 | +$444.2K | +11,181.6%916.7K after | 2 lots |
| Mar 6, 2023 (view filing)4:33 PM ET | Mar 2 | 4 days | Gower Bob GDirector | PPurchase | +90.3K | $0.4883 | +$44.1K | +8.0%1.22M after | |
| Mar 2, 2023 (view filing)3:45 PM ET | Feb 28-Mar 1 | 2 days | Gower Bob GDirector | PPurchase | +379.3K | $0.4808 | +$182.4K | +50.4%1.13M after | 2 lots |
| Feb 1, 2023 (view filing) | Dec 9, 2022 | 54 daysLate | Gower Bob GDirector | PPurchase | +357.1K | $1.40 | +$500.0K | +90.2%753.1K after | |
| May 27, 2022 (view filing)2:05 PM ET | May 25-26 | 2 days | Kirkpatrick LynnChief Executive Officer | PPurchase | +97.0K | $0.4979 | +$48.3K | +34.1%381.9K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Ensysce Biosciences, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 208,833 | $60.6K | 0.00% | +195,263+1,438.9% | Added |
| Adage Capital Partners GP, L.L.C. | 149,711 | $43.4K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 95,391 | $28.0K | 0.00% | +82,078+616.5% | Added |
| Perceptive Advisors LLC | 86,666 | $25.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 86,193 | $25.0K | 0.00% | +28,830+50.3% | Added |
| XTX Topco Ltd | 77,005 | $22.3K | 0.00% | +52,642+216.1% | Added |
| Geode Capital Management, LLC | 62,188 | $18.0K | 0.00% | −11,692−15.8% | Reduced |
| HRT Financial LP | 54,429 | $15.0K | 0.00% | +54,429 | New |
| Susquehanna International Group, LLP | 34,280 | $9.94K | 0.00% | +34,280 | New |
| Tru Independence Asset Management 2, LLC | 13,000 | $3.77K | 0.00% | 00.0% | Unchanged |